-transparent.png){kind=logo}
Serum concentration of dantrolene and its active metabolite, 5-hydroxydantrolene were determined in 27 cerebral palsy patients. Correlation coefficients between the oral dose of dantrolene and serum levels of dantrolene and its major metabolite, 5-hydroxydantrolene were rather small in cerebral palsy patients. The mean half-times of dantrolene and 5-hydroxydantrolene were 3.41 (n = 6) and 4.00 (n = 5) hours, respectively. These values were about a half of those reported earlier [Lietman et al., 1974; Meyler et al., 1979; Flewellen et al., 1983]. The poor correlation between serum level and dose may be due to the variation in an extent of oral dantrolene availability.
Related Publications
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
January 1986,
Diabetes research and clinical practice,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
August 2022,
BMC pediatrics,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
August 1973,
Archives of physical medicine and rehabilitation,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
September 1979,
European journal of clinical pharmacology,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
March 2010,
Developmental medicine and child neurology,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
February 2013,
Annals of rehabilitation medicine,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
January 1980,
Folia psychiatrica et neurologica japonica,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
November 2017,
Pharmacopsychiatry,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
December 1980,
Developmental medicine and child neurology,
N Inotsume, and
A Higashi, and
I Matsukane, and
S Chikazawa, and
M Nakano, and
I Matsuda
July 1988,
Clinical pharmacology and therapeutics,
